Plenary meeting "Guidelines implementation" part 1

12:00-14:00

Arrival and buffet lunch

14:00-14:05

Welcome from the CRT Chairpersons

Alexandra Goncalves (BMS)

Thomas F. Lüscher  

14:05 -18:40

SESSION 1.1 – Financial and structural aspects of guideline implementation

Moderated by: Thomas F. Lüscher and Tamara Krcmar ( Servier International)  

14:05-14:35

ESC Guidelines and the aspiration of the ESC virtuous circle (Guidelines, Quality Indicators, Education, Registries)

Eva Prescott

14:35-14:55

Global implementation of guidelines

Salim Yusuf 

14:55-15:25

Industry perspectives on guideline implementation

 Ricardo Rocha (Intellia Therapeutics)

Alphons Vincent (Medtronic)

15:25-15:40

Socioeconomic barriers to access to care

Chris Gale 

15:40-15:55

Role of registries in identifying gaps in GL implementation

15:55-16:10

Multi-level barriers to the implementation of guideline directed treatments in heart failure

Harriette Van Spall (via zoom)

16:10-16 :30

PANEL DISCUSSION

16:30-16:45

Coffee break

16:45-17:15

BREAKOUT SESSIONS: What are the main challenges for guideline implementation?

Group 1: Within healthcare systems

Lead: Piotr Jankowski

Rapporteur: Andre Krueger (Novartis)  

Group 2: Financial barriers, locally and nationally 

Lead: Nardiner Bhalla (BMS) 

Rapporteur: Julie Sanders   

Group 3: The physicians 

Lead: Elena Arbelo

Rapporteur: Chris Plummer

17:15-17:20

Report from breakout session 1 – 10 mins

Rapporteur: Andre Krueger (Novartis)  

17:20-17:25

Report from breakout session 2 – 10 mins 

Rapporteur: Julie Sanders 

17:25-17:30

Report from breakout session 3 – 10 mins 

Rapporteur: Chris Plummer

SESSION I.2: Guideline implementation from patient perspective

Moderated by: Suleman Aktaa and Jessica Dolan (GE Healthcare)

17:30-17:45

Patient perspective & PREMs

Richard Mindham (ESC Patient form)

17:45-18:00

Adherence issues

Tamara Krcmar (Servier International)

18:00-18:15

Role of nurse-led clinics in addressing patient adherence and implementation of guidelines

Izabella Uchmanowicz

18:15-18:30

PANEL DISCUSSION

18:30-18:40

Wrap-up and summary day 1 – Outlook to day 2

Alexandra Goncalves (BMS)

Thomas F. Lüscher

END OF DAY 1

19:15

20:00

APERITIF

DINNER

08:20-08:30

Summary of day 1

Eva Prescott

Ricardo Rocha (Intellia Therapeutics)

08:30 - 12:10

SESSION 2: ESC perspective of Guidelines implementation: challenges & learnt lessons

Moderated by : Eva Prescott, Ricardo Rocha (Intellia Therapeutics)

08:30-09:00

Highlights from questionnaire

Suleman Aktaa

09:00-09:30

Guideline implementation in eastern European & developing countries: a testimony from Serbia and Syria

Amr Abdin

Marija Polovina

09:30-09:45

Does the EU regulatory system facilitate or hinder equal access to novel cardiovascular drugs across Europe?

09:45-10:00

Appropriate implementation of ESC guidelines - what do Atlas data tell us?

Panos Vardas

10:00-10:15

EuroAspire registry: lessons learned on implementation

Bill Mcevoy

10:15-10:30

Current implementation of AF guidelines and ESC initiatives: the STEEER AF Study

Isabelle C. Van Gelder (via zoom)

10:30-10:45

PANEL DISCUSSION

10:45-11:00

Coffee break

11:00-11:45

BREAKOUT SESSIONS

How can we collectively work to improve quality of care?

Group 4: Access to care: Optimising health care systems 

Lead: Gorav Batra

Rapporteur: Francisco Javier Rossello Lozano

Group 5: Access to care: Optimising affordability  

 Lead:  Kevin O’Gallagher

Rapporteur: Bettina Kraus (BI)

Group 6: Access to care: Optimising individual clinical care 

Lead: Bianca Rocca 

Rapporteur: Christian Hassager 

11:45-11:55

Report from breakout session 4 – 10 mins

Rapporteur: Francisco Javier Rossello Lozano

11:55-12:05

Report from breakout session 5 – 10 mins 

Rapporteur: Bettina Kraus (BI)

12:05-12:15

Report from breakout session 6 – 10 mins 

Rapporteur:  Christian Hassager 

12:15 -12:20

Wrap-up, conclusions, next steps for publication

Thomas F. Lüscher 

END OF DAY 2

12:20

Buffet lunch and departures